What's in DAVA PHARMS INC's pipeline?

DAVA PHARMS INC has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with DAVA PHARMS INC's portfolio?

Top competitors by shared drug class: Epic Pharma Llc.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dava-pharms-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

DAVA PHARMS INC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DAVA PHARMS INC pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Pyrazinamide	PYRAZINAMIDE	marketed	Antimycobacterial [EPC]	Cytochrome P450 3A4	Infectious Disease	1971-01-01

Therapeutic area mix

Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Epic Pharma Llc · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for DAVA PHARMS INC:

Cite this brief

Drug Landscape (2026). DAVA PHARMS INC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dava-pharms-inc. Accessed 2026-06-10.